𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II Study of Weekly Gemcitabine and Vinorelbine for Children With Recurrent or Refractory Hodgkin's Disease: A Children's Oncology Group Report

✍ Scribed by Cole, P. D.; Schwartz, C. L.; Drachtman, R. A.; de Alarcon, P. A.; Chen, L.; Trippett, T. M.

Book ID
126685214
Publisher
American Society of Clinical Oncology
Year
2009
Tongue
English
Weight
102 KB
Volume
27
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of homoharringtonine fo
A phase II study of homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: A pediatric oncology group study
✍ Bell, Beverly A. ;Chang, Myron N. ;Weinstein, Howard J. πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 106 KB

## Abstract ## Background Homoharringtonine (HHT) is a plant alkaloid that is derived from a Chinese evergreen tree. Its mechanism of action is thought to be by inhibition of protein, DNA, and RNA synthesis by inhibition of chain initiation. The treatment of acute myelogenous leukemia (AML) in chi

Phase 2 study of temozolomide in childre
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors : A report from the Children's Oncology Group
✍ H. Stacy Nicholson; Cynthia S. Kretschmar; Mark Krailo; Mark Bernstein; Richard πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 107 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Effective chemotherapy is lacking for most types of central nervous system (CNS) tumors in children. Temozolomide, an agent with activity against adult brain tumors, was investigated in children and adolescents with recurrent CNS tumors. ## METHODS. Temozolomide was ad